(Q43286764)
Statements
Activity of fulvestrant 500 mg versus anastrozole 1 mg as first-line treatment for advanced breast cancer: results from the FIRST study (English)
John F R Robertson
Antonio Llombart-Cussac
David Feltl
John Dewar
Euan Macpherson